Egetis Therapeutics AB (publ) (EGTX) — Cash Flow-to-Debt Ratio
Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow-to-Debt Ratio of -0.20x as of June 2025, meaning its operating cash flow of Skr-59.00 Million could theoretically repay 0% of its total liabilities (Skr299.30 Million) in one year. Check Egetis Therapeutics AB (publ) total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Egetis Therapeutics AB (publ) Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Egetis Therapeutics AB (publ) across 15 annual periods. Also explore how large is Egetis Therapeutics AB (publ)'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Egetis Therapeutics AB (publ) (2010–2024)
Year-by-year debt coverage analysis for Egetis Therapeutics AB (publ). For market capitalisation and broader financial context, see EGTX stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.76x | Skr-227.90 Million | Skr299.40 Million | ▲ +41.3% |
| 2023 | -1.30x | Skr-278.40 Million | Skr214.60 Million | ▲ +59.0% |
| 2022 | -3.16x | Skr-173.50 Million | Skr54.90 Million | ▼ -2.6% |
| 2021 | -3.08x | Skr-130.11 Million | Skr42.23 Million | ▼ -504.9% |
| 2020 | -0.51x | Skr-134.64 Million | Skr264.34 Million | ▲ +79.5% |
| 2019 | -2.49x | Skr-62.64 Million | Skr25.20 Million | ▲ +29.8% |
| 2018 | -3.54x | Skr-80.31 Million | Skr22.68 Million | ▲ +52.3% |
| 2017 | -7.42x | Skr-86.55 Million | Skr11.66 Million | ▼ -41.3% |
| 2016 | -5.25x | Skr-36.12 Million | Skr6.87 Million | ▲ +55.5% |
| 2015 | -11.82x | Skr-51.15 Million | Skr4.33 Million | ▼ -265.8% |
| 2014 | -3.23x | Skr-41.38 Million | Skr12.81 Million | ▲ +53.3% |
| 2013 | -6.92x | Skr-28.07 Million | Skr4.06 Million | ▼ -41.1% |
| 2012 | -4.90x | Skr-31.96 Million | Skr6.52 Million | ▼ -32.6% |
| 2011 | -3.70x | Skr-14.40 Million | Skr3.89 Million | ▼ -104.5% |
| 2010 | -1.81x | Skr-2.72 Million | Skr1.50 Million | — |